UBS Initiates Coverage On Select Medical Hldgs with Neutral Rating, Announces Price Target of $26
Portfolio Pulse from Benzinga Newsdesk
UBS analyst A.J. Rice has initiated coverage on Select Medical Holdings (NYSE:SEM) with a Neutral rating and set a price target of $26.

November 30, 2023 | 1:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS has initiated coverage on Select Medical Holdings with a Neutral rating and a price target of $26.
The initiation of coverage by UBS with a Neutral rating suggests a balanced view on the stock, without a strong bullish or bearish bias. The price target of $26 provides a reference point for investors but does not imply significant upside or downside, hence the neutral score. The relevance is high as the news is directly about SEM. The importance is marked at 75, considering that analyst coverage can influence investor perception and stock price, but it is not a guarantee of movement. The confidence level is high due to the clear stance of the analyst and the specificity of the price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100